Greenpro Capital's (GRNQ) Celmonze to IPO in 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Greenpro's Incubatee Company, Celmonze Plans to Go Public to the U.S. Capital Market
November 3, 2022 9:03 AM EDTKUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 3, 2022 / Greenpro Capital Corp. (NASDAQ: GRNQ) today announced that its incubation company, Celmonze plans to go public to the U.S. Capital Market in year 2023.
Celmonze focuses on skincare and beauty products businesses in Malaysia and Singapore since year 2000. Celmonze International Laboratories now comprises of five research labs located across Europe and North America, with its headquarters based in Paris, France. Celmonze now has more than 80 outlets to serve the market and will continuously growing to a targeted 200 outlets across the ASEAN region.... More
